BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show”

Core Insights - BioRestorative Therapies, Inc. is focused on regenerative medicine, particularly stem cell-based therapies and products, and has recently achieved key clinical and regulatory milestones [1][2] - The CEO, Lance Alstodt, discussed significant commercial opportunities during an interview on "The Big Biz Show," which is widely broadcasted [2][4] Company Overview - BioRestorative develops therapeutic products using adult stem cells, with two main clinical development programs: the Disc/Spine Program and the Metabolic Program [5][6] - The Disc/Spine Program features BRTX-100, a cell therapy candidate for treating painful lumbosacral disc disorders, currently in Phase 2 clinical trials [5] - The Metabolic Program, known as ThermoStem, targets obesity and metabolic disorders using brown adipose-derived stem cells to generate brown adipose tissue [6] Commercial Initiatives - BioRestorative operates a BioCosmeceutical platform, offering a cell-based secretome product aimed at reducing fine lines and wrinkles, with plans to expand into a broader range of aesthetic products [7]